MICROVIABLE THERAPEUTICS
Mission & Vision
Cancer and infectious diseases are two of the leading causes of death in our society, and as scientists, we want to provide a cure.
We are a highly innovative biotechnology company committed to providing new therapeutic solutions for patients with unmet medical needs.
We develop novel biological medicines based on bacteria from the microbiota to address unmet medical needs in oncology and antimicrobial-resistant infectious diseases.
Our proprietary drug development platform, PharmaBiota®, together with a highly qualified team and state-of-the-art facilities, has enabled us to develop three biological assets that are close to the clinical stage.
NEWS
You can follow the latest news of MicroViable in this section
Microviable received funding from Eurostars-3 Program co-financed by CDTI and Horizon Europe
Microviable Therapeutics SL received funding under Eurostars-3 Program co-financed by CDTI (Spanish National Agency) and [...]
Microviable received the MRR High-Impact Paper Award
Microviable has received the 2025 Microbiome Research Reports High-Impact Paper Award, a recognition to an [...]
Microviable present at the Microbiome Times Partnering Forum
During March 18-19th, Microviable will be attending the Microbiome Times Partnering Forum taking place in [...]
CONTACT

Get in touch with us for any questions using the following contact form.



